Breast Implants Market: By Product Type (Silicone breast implants, Structured saline breast implants, Saline breast implants, Gummy bear breast implants, Round breast implants, Smooth breast implants, Textured breast implants), By Treatment Type  (Reconstructive surgery, Cosmetic surgery), By End User (Hospitals, Cosmetology clinics, Ambulatory surgical centres), and Geography  

Breast Implants Market size was valued at USD 1010 million in 2022 and is anticipated to grow at USD 2191 million by 2029 recording a CAGR of 11.7.% from 2023-2029. Breast implants are medical devices, used in the post-mastectomy to improve aesthetic appeal. Breast implants are made up of a silicone outer shell and a filler such as silicone gel or saline. Breast implantation can be done by reconstructive plastic surgery or surgical practice. In the reconstructive surgery process, the implants are inserted to correct deformities and congenital defects of the chest wall and are also used to restore the natural appearance of a breast mound of post-mastectomy breast reconstruction patients. In surgical practice, tissue expander devices are used as temporary breast prostheses to establish and form an implant pocket for the administration of permanent breast implants. In males, pectoral implants are used as a prosthesis for the aesthetic repair and reconstruction of the chest wall to correct the deformities and defects in the chest. For instance, in February 2013, the FDA approved a silicone gel-filled breast implant manufactured by Allergan Plc, which uses more cohesive silicone gel, compared with previously approved breast implants. Similarly, In June 2013, the U.S. FDA approved a silicone gel-filled breast implant that uses a more cohesive silicone gel manufactured by Mentor’s PMA, compared with their previously approved breast implants. Moreover, acquisitions and mergers, collaborations, and key licensing agreements also bolster market growth.  

Breast Implants Market Key Developments

• In December 2008, Johnson & Johnson acquired breast-implant maker Mentor Corporation for the manufacturing of breast implants.
• In March 2015, Actavis plc acquired Allergan, Inc. to manufacture breast implants. Geographically, the breast implant market has been segmented into the following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
• In January 2016, Allergan plc received approval from the U.S. Food and Drug Administration (FDA) to market   Natrelle Inspira Soft touch breast implants. In June 2016, Establishment Labs received approval from the Korean Food & Drug Administration (KFDA) for Motiva Implants.